Clinical Trials Browser

Phase 1 × Niclosamide × 90 days × Clear all

NCT05188170 2026-01-12

Niclosamide in Pediatric Patients With Relapsed and Refractory AML

Phase 1 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute